NEJM study shows CRISPR therapy results in children ages 5-11
Go back to NEJM study shows CRISPR therapy results in children ages 5-11| HCA HOLDINGS, Inc. (NYSE: HCA) | Delayed: 371.87 -1.22 (0.33%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $373.09 | 52 Week High | $83.69 | |||
| Open | $373.26 | 52 Week Low | $60.07 | |||
| Day High | $377.00 | P/E | 110.35 | |||
| Day Low | $371.35 | EPS | $3.37 | |||
| Volume | 842,299 | |||||
